Concord Medical Services ADR(CCM) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Nov 3 at 4:00 PM ET (Korea 11/4 06:00)
Full metrics table
| Index | - | P/E | - | EPS (ttm) | -2.98 | Insider Own | 15.51% | Shs Outstand | 2.8M | Perf Week | 10.31% |
| Market Cap | 0.01B | Forward P/E | - | EPS next Y | - | Insider Trans | - | Shs Float | 2.4M | Perf Month | 23.4% |
| Enterprise Value | 1.05B | PEG | - | EPS next Q | - | Inst Own | 0.79% | Short Float | 0.29% | Perf Quarter | -20.78% |
| Income | -0.01B | P/S | 0.17 | EPS this Y | - | Inst Trans | -3.26% | Short Ratio | 0.15 | Perf Half Y | -20.62% |
| Sales | 0.06B | P/B | - | EPS next 5Y | - | ROA | -1.39% | Short Interest | 0.01M | Perf YTD | -0.26% |
| Book/sh | -69.32 | P/C | 0.25 | EPS past 3/5Y | 43.8% 33.2% | ROE | - | 52W High | -43.38% ($6.80) | Perf Year | -30% |
| Cash/sh | 15.16 | P/FCF | - | Sales past 3/5Y | -2.96% 14.67% | ROIC | -17.8% | 52W Low | 38.24% ($2.79) | Perf 3Y | -65.32% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 69.68% | Gross Margin | 5.67% | Volatility(W/M) | 6.74% 13.46% | Perf 5Y | -84.6% |
| Dividend TTM | - | EV/Sales | 16.44 | Sales Y/Y TTM | 20.26% | Oper. Margin | -51.81% | ATR (14) | 0.44 | Perf 10Y | -91.03% |
| Dividend Ex-Date | 2015/12/23 | Quick Ratio | 0.46 | EPS Q/Q | 51.34% | Profit Margin | -20.21% | RSI (14) | 52.49 | Recom | 5 |
| Dividend Gr. 3/5Y | - | Current Ratio | 0.48 | Sales Q/Q | 58.57% | SMA20 | 4.76% ($3.68) | Beta | -0.78 | Target Price | $1.2 |
| Payout | - | Debt/Eq | - | Earnings | - | SMA50 | -0.03% ($3.85) | Rel Volume | 1.33 | Prev Close | $3.59 |
| Employees | 610 | LT Debt/Eq | - | EPS/Sales Surpr. | -237.42% 8.21% | SMA200 | -9.37% ($4.25) | Avg Volume(3M) | 0.05M | Price | $3.85 |
| IPO | 2009/12/11 | Option/Short | No/Yes | Trades | 1602 | Volume | 61,706 | Change | 7.24% |
Concord Medical Services () is a healthcare holding company that provides full-cycle oncology services in China, spanning cancer diagnosis, treatment, education, and prevention. It features a hybrid operating structure that combines its owned specialized cancer hospitals with a partner hospital network, with a particular focus on high-value cancer care through the integration of proton therapy facilities and AI-based clinical support tools.
Over the past 1 year, roughly in the middle
43% below its 1-year high.
Traded more than usual. That is 133% of its average volume.
CCM has weak earnings and a weak balance sheet
Of every $100 in sales, $51.81 is lost.
Tap to view numbers
Relative to sales, it looks cheap
Loss-making, so we compare on sales. For a company selling $100 a year, you would pay $17. Peers typically go for $94.
Tap to view numbers
Not enough quarters to judge yet
Only 1 quarter(s) reported, so no grade yet.
Tap to view numbers
Opinions on the outlook are split
Analyst sentiment is Strong Sell.
Tap to view numbers
Holding long would have lost money
Bought 5 years ago, your return today would be -84.6%. The S&P 500 did +62% over the same period.
Tap to view numbers
No dividend
There is no profit to distribute yet.
Institutions barely hold it
Institutions hold 0.8%.
Tap to view numbers
It ranks #46 of 48 in the industry
Based on market cap of $11M.
BTMD#43 biote Corp $40M PER 9.3 
PIII#44 P3 Health Partners Inc $28M PER - 
DCGO#45 DocGo Inc $25M PER - CCM#46 Concord Medical Services ADR $11M PER - 
AMS#47 American Shared Hospital Services $8M PER - 
FAQ
What kind of company is CCM?
CCM belongs to the Healthcare sector and operates in the Medical Care Facilities industry.
What is the market cap of CCM?
The market cap of CCM is approximately $11M, ranking 5,408 within its sector.
What is the 52-week high and low for CCM?
CCM has recorded a 52-week high of $6.80 and a low of $2.79.
